SG11201403524RA - Method of reducing exercise-induced joint pain in non-arthritic mammals - Google Patents

Method of reducing exercise-induced joint pain in non-arthritic mammals

Info

Publication number
SG11201403524RA
SG11201403524RA SG11201403524RA SG11201403524RA SG11201403524RA SG 11201403524R A SG11201403524R A SG 11201403524RA SG 11201403524R A SG11201403524R A SG 11201403524RA SG 11201403524R A SG11201403524R A SG 11201403524RA SG 11201403524R A SG11201403524R A SG 11201403524RA
Authority
SG
Singapore
Prior art keywords
joint pain
induced joint
reducing exercise
arthritic
mammals
Prior art date
Application number
SG11201403524RA
Other languages
English (en)
Inventor
Paul Dijkstra
Francis C Lau
James Lugo
Zainulabedin M Saiyed
Original Assignee
Interhealth Nutraceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interhealth Nutraceuticals Inc filed Critical Interhealth Nutraceuticals Inc
Publication of SG11201403524RA publication Critical patent/SG11201403524RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201403524RA 2013-10-24 2014-01-13 Method of reducing exercise-induced joint pain in non-arthritic mammals SG11201403524RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361895332P 2013-10-24 2013-10-24
PCT/US2014/011303 WO2015060888A1 (en) 2013-10-24 2014-01-13 Method of reducing exercise-induced joint pain in non-arthritic mammals

Publications (1)

Publication Number Publication Date
SG11201403524RA true SG11201403524RA (en) 2015-05-28

Family

ID=51610711

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201403524RA SG11201403524RA (en) 2013-10-24 2014-01-13 Method of reducing exercise-induced joint pain in non-arthritic mammals

Country Status (14)

Country Link
US (1) US9066926B2 (enrdf_load_stackoverflow)
KR (1) KR101664290B1 (enrdf_load_stackoverflow)
AR (1) AR095104A1 (enrdf_load_stackoverflow)
AU (1) AU2014202041B8 (enrdf_load_stackoverflow)
BR (1) BR112014011741A2 (enrdf_load_stackoverflow)
CA (1) CA2846644C (enrdf_load_stackoverflow)
CL (1) CL2014001281A1 (enrdf_load_stackoverflow)
CO (1) CO7020846A2 (enrdf_load_stackoverflow)
IN (1) IN2014DE00193A (enrdf_load_stackoverflow)
MX (1) MX347669B (enrdf_load_stackoverflow)
MY (1) MY180106A (enrdf_load_stackoverflow)
PH (1) PH12014501453B1 (enrdf_load_stackoverflow)
SG (1) SG11201403524RA (enrdf_load_stackoverflow)
WO (1) WO2015060888A1 (enrdf_load_stackoverflow)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10226513B2 (en) 2015-01-09 2019-03-12 Mark Terrell Smith Method and composition to prevent or improve symptoms of musculoskeletal distress degeneration
US20180078768A1 (en) * 2016-09-16 2018-03-22 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management using heart sounds
EP3519037B1 (en) 2016-09-27 2020-07-29 Boston Scientific Neuromodulation Corporation Systems for closed-loop pain management
AU2017335497B2 (en) 2016-09-27 2020-01-16 Boston Scientific Neuromodulation Corporation System for pain management using objective pain measure
US11793217B1 (en) 2016-10-04 2023-10-24 Lonza Greenwood Llc Method of manufacture and pasteurization of products containing undenatured collagen
EP3526007A4 (en) 2016-10-12 2020-05-27 Advanced Biomatrix, Inc. THREE-DIMENSIONAL (3-D) PRINTING INKS MANUFACTURED FROM NATURAL EXTRACELLULAR MATRIX MOLECULES
WO2018080887A1 (en) 2016-10-25 2018-05-03 Boston Scientific Neuromodulation Corporation System for pain management using baroreflex sensitivity
US10675469B2 (en) 2017-01-11 2020-06-09 Boston Scientific Neuromodulation Corporation Pain management based on brain activity monitoring
US10631776B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on respiration-mediated heart rates
US10729905B2 (en) 2017-01-11 2020-08-04 Boston Scientific Neuromodulation Corporation Pain management based on muscle tension measurements
US11089997B2 (en) 2017-01-11 2021-08-17 Boston Scientific Neuromodulation Corporation Patient-specific calibration of pain quantification
EP3568861B1 (en) 2017-01-11 2024-12-11 Boston Scientific Neuromodulation Corporation Pain management based on emotional expression measurements
US10631777B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on functional measurements
US10960210B2 (en) 2017-02-10 2021-03-30 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management with sleep detection
CN106713191B (zh) * 2017-02-28 2020-09-08 西安电子科技大学 一种多级搜索sage方法
CN107048412A (zh) * 2017-04-26 2017-08-18 北京盛美诺生物技术有限公司 一种含有ⅱ型胶原蛋白的咀嚼型产品
EP3655091B1 (en) 2017-07-18 2021-08-25 Boston Scientific Neuromodulation Corporation Sensor-based pain management systems
BR112020003598A8 (pt) * 2017-08-21 2021-07-13 Lonza Llc composição e suplemento nutricional feito da mesma
BR112020004053A2 (pt) * 2017-08-31 2020-09-01 Lonza Llc composição de promoção da saúde e métodos de uso de suplementos
IT201700111939A1 (it) * 2017-10-05 2019-04-05 Jointherapeutics S R L Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
EP3806867A4 (en) * 2018-07-16 2022-07-06 Lonza Consumer Health Inc. COLLAGEN AND CELLULAR MATTER SUPPLEMENT AND METHOD OF ADMINISTRATION
WO2021016665A1 (en) * 2019-07-30 2021-02-04 Atp Institute Pty Ltd A gummy composition
WO2021067452A1 (en) 2019-09-30 2021-04-08 Lonza Consumer Health Inc. Cannabinoid product for improving musculoskeletal health
AU2021213722A1 (en) * 2020-01-29 2022-07-28 Lonza Greenwood Llc Joint health composition and use thereof in healthy mammals
JP2023515867A (ja) 2020-03-03 2023-04-14 ロンザ・グリーンウッド・エルエルシー 食品および飲料用途での非変性ｉｉ型コラーゲンならびにその使用
BR112022019052A2 (pt) 2020-03-24 2022-11-08 Lonza Greenwood Llc Colágeno tipo ii não desnaturado em alimento e petiscos de animal
WO2021252612A1 (en) * 2020-06-12 2021-12-16 Lonza Consumer Health Inc. Undenatured type ii collagen as a supplement for improved endurance, lipid metabolism, and oxidative stress
EP4181947A1 (en) * 2020-08-19 2023-05-24 Lonza Consumer Health Inc. Method for improving inflammation, joint health, joint mobility, and joint comfort in healthy mammals
CN115120618B (zh) * 2021-03-23 2024-01-26 安徽盛美诺生物技术有限公司 具有改善免疫应答作用的软骨提取物、其制备方法及其用途
KR20240101672A (ko) * 2021-11-12 2024-07-02 론자 그린우드 엘엘씨 골격 관절의 치료 방법 및 이의 조성물 및 용도
KR102771944B1 (ko) * 2023-09-25 2025-02-26 (주)온오퍼 고함량 액티브 성분을 갖는 반려동물용 츄 형태 영양제

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
WO1993008784A1 (en) 1991-11-08 1993-05-13 Gunilla Lofgren Nisser Partially occluded contact lens for treating visual and/or brain disorder
US5637321A (en) 1994-02-28 1997-06-10 Moore; Eugene R. Method for preparing animal tissue for use in alleviating the symptoms of arthritis in mammals
US5529786A (en) 1994-02-28 1996-06-25 Moore; Eugene R. Process and product for treatment of rheumatoid arthritis
US5645851A (en) 1994-02-28 1997-07-08 Moore; Eugene R. Product for alleviating the symptons of arthritis in mammals
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
US6372794B1 (en) * 1999-08-26 2002-04-16 Marcel E. Nimni Method for alleviating arthritis in mammals
US20020086070A1 (en) 2000-03-11 2002-07-04 Kuhrts Eric Hauser Anti-inflammatory and connective tissue repair formulations
US7083820B2 (en) 2000-09-29 2006-08-01 Schilling Marvin L Method for producing biologically active products
JP2003048850A (ja) 2001-06-01 2003-02-21 Nippon Meat Packers Inc 関節傷害治療剤及び機能性食品
US20060062859A1 (en) 2004-08-05 2006-03-23 Kenneth Blum Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes
FR2900155B1 (fr) * 2006-04-21 2008-06-27 Diana Naturals Sa Hydrolisat de cartilage aviaire, procede d'obtention et utilisations
US20100215731A1 (en) 2009-02-20 2010-08-26 Maastricht University Method for improving cartilage repair and/or preventing cartilage degeneration in a joint
US20110218151A1 (en) * 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate
CN101822684B (zh) 2010-05-27 2012-08-15 江苏江山制药有限公司 用于防治骨关节痛的复方组合制剂及其制备方法
US20120294898A1 (en) 2011-05-19 2012-11-22 Warsaw Orthopedic, Inc. Injectable dbm for soft tissue repair
CN102423487B (zh) 2011-12-23 2014-04-16 内蒙古伊利实业集团股份有限公司 一种骨关节保健组合物及其应用
CN103203012A (zh) 2012-01-12 2013-07-17 深圳市麦金利实业有限公司 关节保健品

Also Published As

Publication number Publication date
AU2014202041B2 (en) 2019-11-28
IN2014DE00193A (enrdf_load_stackoverflow) 2015-05-01
WO2015060888A1 (en) 2015-04-30
CL2014001281A1 (es) 2015-10-30
AR095104A1 (es) 2015-09-30
MY180106A (en) 2020-11-23
CA2846644C (en) 2018-05-01
MX347669B (es) 2017-05-08
CO7020846A2 (es) 2014-08-11
US9066926B2 (en) 2015-06-30
AU2014202041B8 (en) 2020-04-02
CA2846644A1 (en) 2015-07-13
PH12014501453A1 (en) 2015-01-21
KR20150059132A (ko) 2015-05-29
AU2014202041A1 (en) 2015-05-14
KR101664290B1 (ko) 2016-10-11
MX2014002934A (es) 2015-09-21
PH12014501453B1 (en) 2015-01-21
BR112014011741A2 (pt) 2017-05-30
US20150119335A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
SG11201403524RA (en) Method of reducing exercise-induced joint pain in non-arthritic mammals
IL281356B (en) Injector and assembly method
IL243979A0 (en) Syringe and assembly method
SG11201510747RA (en) Method for increasing expression of rna-encoded proteins
GB201318390D0 (en) Opto-physiological sensor and method of design
EP2943710A4 (en) JOINT FOR ASSEMBLING TUBES AND METHOD FOR ASSEMBLING TUBES
EP3588586C0 (en) PHOTOVOLTAIC DEVICES AND MANUFACTURING METHOD
GB201305414D0 (en) Method and composition
IL240812B (en) Unit and method for corona treatment
PL3003591T3 (pl) Nastawne urządzenie do usuwania zgorzeliny i sposób działania nastawnego urządzenia do usuwania zgorzeliny
AP2016009013A0 (en) Fairing and method
PL3071969T3 (pl) Sposób analizy
ZA201600927B (en) Structural assembly and method of assembly thereof
ZA201604113B (en) Siliceous composition and method for obtaining same
GB201322451D0 (en) Purification method and compositions
EP2904586A4 (en) METHOD FOR DESCRIBING OBJECT POINTS OF THE OBJECT SPACE AND CONNECTING IT FOR ITS IMPLEMENTATION
EP3045232A4 (en) APPLICATOR AND ORDER PROCEDURE
SG11201605104QA (en) An improved beverage and method of manufacture
IL239812A0 (en) Method and composition for the treatment of arthritis and osteoarthritis
SG11201603190QA (en) Acupressure pillow and method of applying acupressure
GB201518035D0 (en) Prebiotic composition and method of its use
GB201515529D0 (en) Injector and method
GB201415693D0 (en) Method of Measuring Insulation
PL2848366T3 (pl) Tokarka oraz sposób
GB201314498D0 (en) Improvements to Receivers and Method of Use Thereof